Name Address/P.O. Box Postal Code/City Country Contact Person Telephone Fax Email Website Social Media Number of Employees Founded (year) Type of Laboratory Areas of Activity
External Collaborations Request for Further Collaborations
›
Coriolis Pharma Research GmbH
›
Fraunhoferstr. 18B 82152 Martinsried Germany Dr Jörg Müller +49-89-417760-111 +49-89-417760-222 Joerg.Mueller@coriolis-pharma.com www.coriolis-pharma.com
›
I
› › › › › › ›
› › ›
›
›
›
150+ 2008 Contract research and development Formulation excellence for biopharmaceuticals, incl.: | Liquid and lyophilised formulations | Lyophilisation process development | Analytical services for biologics | Aggregate & particle analysis | Particle identification | Higher-order structure analysis | Forced-degradation studies | Long-term and in-use stability | Pre-formulation screening | Developability assessment | Supply of TOX-material | Level: R&D, GMP, S1 (BSL1), S2 (BSL2) Experience with 750+ different molecules gained in 1,500+ projects Worldwide clients in all stages of product development (early R&D to and beyond market approval). We collaborate with small virtual biotech firms, mid-size pharma-biotech, as well as TOP20 pharma-biotech companies. Approach our experts with your formulation, stability, and analytical challenges. We provide tailor-made, science-driven solutions that align with your development strategy.
Your partner with scientific excellence Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs including proteins, vaccines, gene- and cell therapy products, viral vectors, nucleic acids, antibodies and related products, peptides, drug delivery systems, and small molecules. More than 700 customers – from start-ups to Big Pharma – trust the expertise of Coriolis. We develop liquid and lyophilised formulations entirely in-house. For each individual project, our highly skilled scientists develop tailor-made study designs that align with our customers’ drug development strategies. Our formulation services support all phases of drug development from early R&D to and beyond market approval.
Coriolis is specialised in the provision of: › Formulation development services for liquid and lyophilised products including BSL1 and BSL2 · Pre-formulation and candidate selection · Early stage formulation development · Late phase formulation development · Lyophilisation process development · Lyophilisation cycle optimisation · Robustness, scale-up, and transfer studies › Developability / manufacturability assessment › Support in container closure system selection › In-use stability studies › Stability testing including forced degradation studies › R&D and cGMP-compliant contract analytical services › Orthogonal analysis of subvisible aggregates and particles incl. particle identification › Testing of BSL1 and BSL2 GMO material › Polysorbate analytics › Biosimilarity studies › Supply of preclinical Tox-material › Outstanding scientific expertise
